Walmart Launches Clinical Research Sites in Former Health Clinics to Expand Trial Access in Underserved Communities

Walmart查看公司主页 will launch clinical research sites this spring in a limited number of stores and former health clinic locations, marking the retail giant's expansion into community-based clinical trials. The initiative, announced through a partnership between Walmart Healthcare Research Institute (搜索)搜索该词条 (WHRI) and independent clinical research firm Care Access (搜索)搜索该词条, will establish research sites in three former Walmart Health locations and one rural Walmart store.

Addressing Geographic and Access Barriers

The new research sites aim to bring clinical trial opportunities to markets that typically lack access to the latest studies, particularly in rural areas where large academic medical centers are often distant. Dr. Emily Aaronson, Walmart查看公司主页's Chief Medical Officer, emphasized the community-centered approach: "As healthcare evolves, it is becoming clear that meaningful progress happens when care starts closer to home. The future of health will not be built only in large academic medical centers. It will also be shaped in neighborhoods, towns and rural communities, in places people already trust and rely on everyday."

Each site will host Care Access (搜索)搜索该词条 clinical teams who will offer health screenings, share information about research opportunities, and help individuals explore participation in studies without traveling far from home. According to Aaronson, "By reimagining familiar spaces as places for research engagement, we think it will reduce one of the most common barriers to participation."

Focus on Underrepresented Populations

The initiative addresses a critical need for diversity in clinical trials. The U.S. Food and Drug Administration (搜索)搜索该词条 acknowledged in 2022 that racial and ethnic minorities are "frequently underrepresented in biomedical research." The agency outlined steps to improve diversity in clinical trials, noting that an estimated 1 in 5 drugs have varied responses in ethnic groups, yet most clinical trial participants are white.

WHRI, launched in October 2022, specifically focuses on "innovative interventions and medications that can make a difference in underrepresented communities including older adults, rural residents, women and minority populations," according to Walmart查看公司主页's initial announcement of the institute.

Expanding Clinical Research Infrastructure

Walmart查看公司主页's entry into clinical research reflects a broader trend of expanding trial infrastructure beyond traditional academic centers. The move comes as hospital systems have expanded clinical trials and retail pharmacies like Walgreens查看公司主页 have begun conducting research. These sites typically operate through contracts with drug companies or government research grants.

The research sites are designed to provide participants with potential benefits including early access to innovative treatments and therapies. As WHRI stated, "For some participants, research can offer additional options when standard approaches are limited. For all participants, it provides an opportunity to contribute to medical advances that can benefit others in their community and beyond."

Community-Centered Healthcare Strategy

The clinical research initiative aligns with Walmart查看公司主页's broader healthcare strategy focused on community accessibility. Aaronson noted that "People want support that fits into their routines and respects their time. When care feels easier to navigate and closer to home, it becomes more approachable and more human."

This approach builds on Walmart查看公司主页's previous community health initiatives, including mobile community health screening events that have demonstrated success in engaging local populations in healthcare research opportunities.

The specific store locations and former health clinic sites for the research facilities have not yet been finalized, according to a Walmart查看公司主页 spokesperson. The company did not comment on potential future revenues from the research sites.